COVID 19 y enfermedad hepática: un panorama que está siendo aclarado



Palabras clave:

COVID 19, Enfermedad hepática


Los datos de descargas todavía no están disponibles.

Biografía del autor/a

Rolando Ortega-Quiróz , Clínica general del Norte

MD, MSc. Medicina Interna-Gastroenterología - Hepatología, Unidad de Hepatología y Fibroscan, Clínica General del Norte. Docente de Posgrado en Medicina Interna, Universidad Libre. Fellow de la Asociación Americana para
el Estudio del Hígado (FAASLD). Barranquilla, Colombia.

Referencias bibliográficas

Boyton RJ, Altmann DM. The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions? Nat Rev Immunol. 2021;21(12):762-768.

Peeling RW, Heymann DL, Teo YY, Garcia PJ. Diagnostics for COVID-19: moving from pandemic response to control. Lancet. 2022;399(10326):757-768.

COVID-19 Excess Mortality Collaborators. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21. Lancet. 2022;399(10334):1513-36.

Wong L, Perlman S. Immune dysregulation and immnunopathology induced by SARS-CoV-2 and related coronaviruses-are we our own worst enemy? Nat Rev Immunol. 2021;22(1):47-56.

Majdoul S, Compton AA. Lessons in self-defence: inhibition of virus entry by intrinsic immunity. Nat Rev Immunol. 2022;22(6):339-352.

Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(3):141-154.

Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. 2022;23(2):194-202.

Desai AD, Lavelle M, Boursiquot BC, Wan EY. Long-term complications of COVID-19. Am J Physiol Cell Physiol. 2022;322(1):C1-C11.

Niemi MEK, Daly MJ, Ganna A. The human genetic epidemiology of COVID-19. Nat Rev Genet. 2022:1–14.

Levy E, Stintzi A, Cohen A, Desjardins Y, Marette A, Spahis S. Critical appraisal of the mechanisms of gastrointestinal and hepatobiliary infection by COVID-19. Am J Physiol Gastrointest Liver Physiol. 2021;321(2):G99-G112.

Marasco G, Cremon C, Barbaro M, Salvi D, Cacciari G, Kagramanova A, et al. Prevalence of gastrointestinal symtoms in severe acute respiratory syndrome coronavirus-2 infection: Results of the prospective controlled multinational GI-COVID-19 study. Am J Gastroenterol 2021;117(1):147-157.

Sansoè G, Aragno M, Wong F. COVID-19 and Liver Cirrhosis: Focus on the Nonclassical Renin-Angiotensin System and Implications for Therapy. Hepatology. 2021;74(2):1074-1080.

Marjot T, Webb GJ, Barritt AS 4th, Moon AM, Stamataki Z, Wong VW, et al. COVID-19 and liver disease: mechanistic and clinical perspectives. Nat Rev Gastroenterol Hepatol. 2021;18(5):348-364.

Ekpanyapong S, Bunchorntavakul C, Reddy KR. COVID-19 and the Liver: Lessons Learnt from the EAST and the WEST, A Year Later. J Viral Hepat. 2022;29(1):4-20.

Julien J, Ayer T, Tapper EB, Barbosa C, Dowd WN, Chhatwal J. Effect of increased alcohol consumption during COVID-19 pandemic on alcohol-associated liver disease: A modeling study. Hepatology. 2022;75(6):1480-1490.

Gonzalez HC, Zhou Y, Nimri FM, Rupp LB, Trudeau S, Gordon SC. Alcohol-related hepatitis admissions increased 50% in the first months of the COVID-19 pandemic in the USA. Liver Int. 2022;42(4):762-764.

Spearman CW, Aghemo A, Valenti L, Sonderup MW. COVID-19 and the liver: A 2021 update. Liver Int. 2021;41(9):1988-1998.

Asselah T, Durantel D, Pasmant E, Lau G, Schinazi RF. COVID-19: Discovery, diagnostics and drug development. J Hepatol. 2021;74(1):168-184.

Asemota J, Aduli F. The Impact of Nonalcoholic Fatty Liver Disease on the Outcomes of Coronavirus Disease 2019 Infection. Clin Liver Dis (Hoboken). 2022;19(1):29-31.

Efe C, Dhanasekaran R, Lammert C, Ebik B, Higuera-de la Tijera F, Aloman C, et al. Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study. Hepatology. 2021;73(6):2099-2109.

Martinez MA, Franco S. Impact of COVID-19 in Liver Disease Progression. Hepatol Commun. 2021;5(7):1138-1150.

Moreira JLS, Barbosa SMB, Vieira JG, Chaves NCB, Gonçalves Júnior J. Liver histopathological changes and COVID-19: What does literature have to tell us? Dig Liver Dis. 2022;54(3):296-298.

Saviano A, Wrensch F, Ghany MG, Baumert TF. Liver Disease and Coronavirus Disease 2019: From Pathogenesis to Clinical Care. Hepatology. 2021;74(2):1088-1100.

Nardo AD, Schneeweiss-Gleixner M, Bakail M, Dixon ED, Lax SF, Trauner M. Pathophysiological mechanisms of liver injury in COVID-19. Liver Int. 2021;41(1):20-32.

Camacho-Domínguez L, Rodríguez Y, Polo F, Restrepo Gutierrez JC, Zapata E, Rojas M, et al. COVID-19 vaccine and autoimmunity. A new case of autoimmune hepatitis and review of the literature. J Transl Autoimmun. 2022;5:100140.

Bartoli A, Cursaro C, Andreone P. Severe acute respiratory syndrome coronavirus-2-associated cholangiopathies. Curr Opin Gastroenterol. 2022;38(2):89-97.

McConnell MJ, Kondo R, Kawaguchi N, Iwakiri Y. Covid-19 and Liver Injury: Role of Inflammatory Endotheliopathy, Platelet Dysfunction, and Thrombosis. Hepatol Commun. 2022;6(2):255-269.

Marjot T, Moon AM, Cook JA, Abd-Elsalam S, Aloman C, Armstrong MJ, et al. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study. J Hepatol. 2021;74(3):567-577.

Ge J, Pletcher MJ, Lai JC; N3C Consortium. Outcomes of SARS-CoV-2 Infection in Patients With Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study. Gastroenterology. 2021;161(5):1487-1501.e5.

Mendizabal M, Piñero F, Ridruejo E, Anders M, Silveyra MD, Torre A, et al. Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission. Ann Hepatol. 2021;21:100298.

Mahmud N, Kaplan DE, Goldberg DS, Taddei TH, Serper M. Changes in Hepatocellular Carcinoma Surveillance and Risk Factors for Noncompletion in the Veterans Health Administration Cohort During the Coronavirus Disease 2019 Pandemic. Gastroenterology. 2021;160(6):2162-2164.e3.

Muñoz-Martínez S, Sapena V, Forner A, Nault JC, Sapisochin G, Rimassa L, et al. Assessing the impact of COVID-19 on liver cancer management (CERO-19). JHEP Rep. 2021;3(3):100260.

Merola J, Schilsky M, Mulligan D. The impact of COVID-19 on organ donation, procurement, and liver transplantation in the United States. Hepatol Comm. 2021;5(1):5-11.

Philips CA, Rela M, Soin AS, Gupta S, Surendran S, Augustine P. Critical Update on the Diagnosis and Management of COVID-19 in Advanced Cirrhosis and Liver Transplant Recipients. J Clin Transl Hepatol. 2021;9(6):947-959.

Belli LS, Fondevila C, Cortesi PA, Conti S, Karam V, Adam R, et al. Protective Role of Tacrolimus, Deleterious Role of Age and Comorbidities in Liver Transplant Recipients With Covid-19: Results From the ELITA/ELTR Multi-center European Study. Gastroenterology. 2021;160(4):1151-1163.e3.

Altmann DM, Boyton RJ. COVID-19 vaccination: The road ahead. Science. 2022;375(6585):1127-1132.

Fix OK, Blumberg EA, Chang KM, Chu J, Chung RT, Goacher EK, et al. American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease. Hepatology. 2021;74(2):1049-1064.

Calleri A, Saracco M, Pittaluga F, Cavallo R, Romagnoli R, Martini S. Seroconversion after coronavirus disease 2019 vaccination in patients awaiting liver transplantation: Fact or Fancy. Liver Transplantation 2022;28(2):180-187.

Becchetti C, Broekhoven AGC, Dahlqvist G, Fraga M, Zambelli MF, Ciccarelli O, et al. Humoral response to SARS-CoV-2 infection among liver transplant recipients. Gut. 2022;71(4):746-756.

John BV, Deng Y, Khakoo NS, Taddei TH, Kaplan DE, Dahman B. Coronavirus Disease 2019 Vaccination Is Associated With Reduced Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Death in Liver Transplant Recipients. Gastroenterology. 2022;162(2):645-647.e2.

Gabrielli M, Franza L, Esperide A, Gasparrini I, Gasbarrini A, Franceschi F, et al. Liver Injury in Patients Hospitalized for COVID-19: Possible Role of Therapy. Vaccines (Basel). 2022;10(2):192.

de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C; Baveno VII Faculty. Baveno VII - Renewing consensus in portal hypertension. J Hepatol. 2022;76(4):959-974.



Cómo citar

Ortega Quiróz, R. J. (2022). COVID 19 y enfermedad hepática: un panorama que está siendo aclarado. Revista Colombiana De Gastroenterología, 37(2), 131–135.